top of page

Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays

Paul Matteis comments on Biogen and Vertex earnings, discusses recent news on BioMarin and Sage, and highlights Xenon, Neumora, Karuna, Cerevel, and others.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page